Previous Close | 3.6300 |
Open | 3.6200 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 3.3200 - 3.7003 |
52 Week Range | 1.8800 - 7.2230 |
Volume | |
Avg. Volume | 183,347 |
Market Cap | 109.834M |
Beta (5Y Monthly) | 0.51 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.8700 |
Earnings Date | Nov 06, 2024 - Nov 11, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 12.50 |
As the major U.S. stock indexes hover near record levels, investors are keenly observing market movements and economic indicators for signs of stability and growth. Penny stocks, although an antiquated term, continue to capture interest by offering potential growth opportunities at lower price points. When these smaller or newer companies boast strong financial health and solid fundamentals, they present a unique chance to discover value in the market's less-traveled paths.
Potential Relmada Therapeutics, Inc. ( NASDAQ:RLMD ) shareholders may wish to note that the CEO & Director, Sergio...